Arrow Electronics Inc. (ARW) is Trading Lower on Unusual Volume for February 05

Equities Staff |

Arrow Electronics Inc. (ARW) experienced unusually high volume on Feb. 05, as the stock lost 1.17% to a closing price of $54.75. The stock saw 1.28 million shares trade hands over the course of the day on 13,275 trades. Given that the stock’s average daily volume over the last month has been 623,948 shares a day, this represents a pretty substantial spike over the norm.

Arrow Electronics Inc. has a P/B ratio of 1.23. It also has a P/E ratio of 10.6. The stock has traded between $64.98 and $45.23 over the last 52-weeks, its 50-day SMA is now $52.94, and its 200-day SMA $56.56.

Arrow Electronics Inc is a provider of products, services, and solutions to industrial and commercial users of electronic components and enterprise computing solutions.

Headquartered in Centennial, CO, Arrow Electronics Inc. has 17,000 employees and is currently under the leadership of CEO Michael J. Long.

For a complete fundamental analysis analysis of Arrow Electronics Inc., check out’s Stock Valuation Analysis report for ARW. To see the latest independent stock recommendations from’s analysts, visit our Research section.


The Russell 3000 is not well known outside the world of finance, but it’s one of the strongest indices out there for getting a broad sense of the stock market. Unlike the better-known Dow Jones Industrial Average or S&P 500, membership on the Russell 3000 isn’t selected by committee. It’s simply the 3,000 most valuable companies in the country.

With 3,000 stocks making up the index, it gives a broad look at the markets, including the small-and mid-cap companies that aren’t on the Dow or the S&P 500. And with a rules-based system for determining membership, there’s no bias that could potentially limit membership. That’s why many financial professionals will turn to the Russell 3000 long before the better-known indices when trying to take the temperature of the market.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets


D-Wave Systems is the first quantum computing company. Its mission is to integrate new discoveries in physics, engineering, manufacturing, and computer science into breakthrough approaches to computation to help solve…


Our mission is to be the best place for people who care about music to create and discover thoughtfully curated playlists. In essence, 8tracks is a platform for online mixtapes.